Comedy stars unite for ‘Shake with Laughter’

Perspectives

Author: Joe McAweaneyPublished: 11 October 2017

Prep: Cook: Serves:

‘Shake with Laughter’ – a Parkinson’s comedy fundraiser featuring Rob Deering and Tim Vine – will be performed at London’s iconic Comedy Store on 16 October

On 16 October The Comedy Store, London, UK, will play host to the sixth edition of the Parkinson’s fundraiser ‘Shake with Laughter’.

The annual comedy show, from which all proceeds go to charity Parkinson’s UK, will feature comedians including Rob Deering, Gary Delaney, Lucy Porter, Paul Mayhew-Archer and Tim Vine.

‘Shake with Laughter’ launched in London in 2012 and has since been held in Manchester and Newcastle, with plans to debut in Glasgow next month.

Rob Deering, whose father has Parkinson’s, is a longstanding fundraiser for Parkinson’s UK. The popular stand-up has participated in marathons, comedy events and celebrity quiz shows including Pointless and The Weakest Link. He is currently on track to reach his £100,000 fundraising target over 10 years.

For more information about the event and the comedians taking part, you can visit the Parkinson’s UK website here.

Read more: October 2017 events

Diana Levine: taking photos for a cure

Last Month

Next Month

Go Back

Share this story

Comments

Ann Perkins

Wish the USA offered this. I’ll be glad to self-deprecate with the likes of you.

In my country

Promoting movement therapy at the Parkinson Society in Singapore

Learn about the only Parkinson's support centre in Singapore

Recipe: Slow-cooked Mediterranean chicken tagine

This slow-cooked fragrant tagine benefits from antibacterial properties

Tonya’s trends: ‘off the shoulder’ – a low-slung look on the up

This season’s off the shoulder trend hides DBS surgery scars

Parkinson’s gene therapy could improve motor symptoms

UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s. The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences. The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function. Professor Thomas Foltynie, neurology consultant at University College London Hospitals – which is carrying out the research alongside University College London – said: “Genes that increase the production of dopamine could help alleviate the symptoms of Parkinson’s disease, potentially with fewer side effects than traditional drug treatments, by targeting only the areas of the brain that are lacking in dopamine.”

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

Pharmaceutical company Pfizer has teamed with investment firm Bain Capital to launch Cerevel Therapeutics – a biopharmaceutical company focused on developing drugs for Parkinson’s and other central nervous system conditions. The new company – which will receive US $350 million of investment from Bain Capital – will begin working on phase three clinical trials on a Parkinson’s drug designed to increase levels of dopamine in the brain. Cerevel will also continue to develop several of Pfizer’s drug programmes which closed earlier this year. Marco Baptista, director of research programmes at The Michael J Fox Foundation – which has partnered with Pfizer since 2010 – said: “This is welcome news for Parkinson’s patients and researchers. Pfizer had developed a diverse group of novel therapeutics for Parkinson’s disease, which are now going to get another chance at success. MJFF looks forward to partnering with Cerevel to support the advancement of these promising…

AI technology could diagnose Parkinson’s in less than three minutes

Chinese technology enterprise Tencent has partnered with UK healthcare company Medopad and the Centre of Excellence in Parkinson’s and Movement Disorders at Kings College Hospital, UK, to create artificial intelligence (AI) software that may be able to diagnose Parkinson’s in less than three minutes. The team trained the AI system by analysing video footage of people with Parkinson’s, and believes it will help doctors identify and diagnose the condition at a far earlier stage. In addition, it is hoped the test could be carried out remotely using smartphone technology. Dan Vahdat, CEO and Co-founder of Medopad, said: “Our partnership with Tencent comes from a shared vision to change the future of healthcare as we know it. “In combining Medopad’s medical expertise and Tencent’s technical capabilities, we hope to provide the technology needed to support clinicians to predict preventable complications for people with Parkinson’s disease.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
Captcha
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Comedy stars unite for ‘Shake with Laughter’

Perspectives

Author: Joe McAweaneyPublished: 11 October 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

In my country

Promoting movement therapy at the Parkinson Society in Singapore

Recipes & Nutrition

Recipe: Slow-cooked Mediterranean chicken tagine

Perspectives

Tonya’s trends: ‘off the shoulder’ – a low-slung look on the up

Parkinson’s gene therapy could improve motor symptoms

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

{title}

Subscribe

Comedy stars unite for ‘Shake with Laughter’

Perspectives

Author: Joe McAweaneyPublished: 11 October 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

In my country

Promoting movement therapy at the Parkinson Society in Singapore

Recipes & Nutrition

Recipe: Slow-cooked Mediterranean chicken tagine

Perspectives

Tonya’s trends: ‘off the shoulder’ – a low-slung look on the up

Parkinson’s gene therapy could improve motor symptoms

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

{title}

Subscribe

Sign in